Clicky

Taro Pharmaceutical Industries(TARO)

Description: Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, together with its subsidiaries, engages in the research, development, production, and marketing of pharmaceutical products primarily in the United States, Canada, and Israel. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas comprising topical creams and ointments, liquids, capsules, and tablets principally in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company also develops and manufactures active pharmaceutical ingredients for use in its finished dosage form products. Taro Pharmaceutical Industries Ltd. sells and distributes its products to drug wholesalers and store chains, generic drug distributors, mass merchandisers, food and retail chains, and managed care organizations. The company was founded in 1959 and is based in Haifa Bay, Israel.


Keywords: Pharmaceutical Products Medication Health Sciences Pharmacology Active Pharmaceutical Ingredients Pharmaceutical Sciences Retail Chain Pharmaceutical Industries Managed Care Ointments Store Chains Topical Medication Generic Drug Science And Technology In Israel Counter Pharmaceutical Products Drug Wholesalers Over The Counter Pharmaceutical Products Perrigo Patheon Science Based Pharmaceutical

Home Page: www.taro.com

TARO Technical Analysis

14 Hakitor Street
Haifa, 2624761
Israel
Phone: 972 4 847 5700


Officers

Name Title
Mr. Uday V. Baldota CEO & Director
Mr. William J. Coote VP, CFO & Chief Accounting Officer
Mr. Itamar Karsenti VP & Head of Operations
Mr. Avi Avramoff VP and Head of R&D
Mr. Itzik Baruch VP of Technical Services
Dr. Roman Kaplan VP of Scientific and Technical Compliance Mang.
Mr. Erik Zwicker J.D. VP, Gen. Counsel & Sec.
Mr. Ara Aprahamian VP of Sales & Marketing
Ms. Michele Visosky VP & Head of Human Resource
Mr. Jayesh Shah Head of Procurement

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 9.8135
Trailing PE: 16.7529
Price-to-Book MRQ: 0.7446
Price-to-Sales TTM: 1.9102
IPO Date: 1993-04-01
Fiscal Year End: March
Full Time Employees: 1455
Back to stocks